<div id="readability-page-1"><div><p>Health care stocks ended slightly lower with little fresh news to drive trading.</p><p>    Johnson &amp; Johnson said it closed its $3.05 billion acquisition of Halda Therapeutics, and that the deal is now expected to ding its adjusted earnings by 20 cents a share. Upon disclosing the deal last month, Johnson &amp; Johnson said it would reduce 2026 adjusted earnings by about 15 cents a share due to short-term financing and a charge related to equity awards for Halda employees. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-29-25 1740ET</p></div></div>

強生

<p>醫療保健股票在輕微交易中小幅下跌。強生完成了對 Halda Therapeutics 的 30.5 億美元收購，預計將對其調整後每股收益產生 20 美分的影響。此前，該公司預計由於對 Halda 員工的融資和股權獎勵，2026 年的調整後收益將減少 15 美分</p>

醫療保健股票在清淡的交易中表現參差不齊——醫療保健綜述